181 related articles for article (PubMed ID: 35213904)
1. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants.
Potsiurko S; Dobryanskyy D; Sekretar L; Salabay Z
Am J Perinatol; 2024 Apr; 41(6):730-738. PubMed ID: 35213904
[TBL] [Abstract][Full Text] [Related]
2. Early treatment versus expectant management of hemodynamically significant patent ductus arteriosus for preterm infants.
Mitra S; Scrivens A; von Kursell AM; Disher T
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013278. PubMed ID: 33301630
[TBL] [Abstract][Full Text] [Related]
3. Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus.
Hundscheid T; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Dijkman KP; van Kaam AH; Villamor E; Kroon AA; Visser R; Mulder-de Tollenaer SM; De Bisschop B; Dijk PH; Avino D; Hocq C; Zecic A; Meeus M; de Baat T; Derriks F; Henriksen TB; Kyng KJ; Donders R; Nuytemans DHGM; Van Overmeire B; Mulder AL; de Boode WP;
N Engl J Med; 2023 Mar; 388(11):980-990. PubMed ID: 36477458
[TBL] [Abstract][Full Text] [Related]
4. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants.
Gudmundsdottir A; Johansson S; Håkansson S; Norman M; Källen K; Bonamy AK
Neonatology; 2015; 107(2):87-92. PubMed ID: 25412681
[TBL] [Abstract][Full Text] [Related]
5. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2015 Feb; (2):CD003481. PubMed ID: 25692606
[TBL] [Abstract][Full Text] [Related]
6. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003481. PubMed ID: 30264852
[TBL] [Abstract][Full Text] [Related]
7. Effect of Nonintervention vs Oral Ibuprofen in Patent Ductus Arteriosus in Preterm Infants: A Randomized Clinical Trial.
Sung SI; Lee MH; Ahn SY; Chang YS; Park WS
JAMA Pediatr; 2020 Aug; 174(8):755-763. PubMed ID: 32539121
[TBL] [Abstract][Full Text] [Related]
8. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
[TBL] [Abstract][Full Text] [Related]
9. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD010061. PubMed ID: 31985831
[TBL] [Abstract][Full Text] [Related]
10. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
[TBL] [Abstract][Full Text] [Related]
11. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
[TBL] [Abstract][Full Text] [Related]
12. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2013 Apr; (4):CD003481. PubMed ID: 23633310
[TBL] [Abstract][Full Text] [Related]
13. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
[TBL] [Abstract][Full Text] [Related]
14. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
[TBL] [Abstract][Full Text] [Related]
15. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants.
Jasani B; Mitra S; Shah PS
Cochrane Database Syst Rev; 2022 Dec; 12():CD010061. PubMed ID: 36519620
[TBL] [Abstract][Full Text] [Related]
16. Multi-centre, randomised non-inferiority trial of early treatment versus expectant management of patent ductus arteriosus in preterm infants (the BeNeDuctus trial): statistical analysis plan.
Hundscheid T; Donders R; Onland W; Kooi EMW; Vijlbrief DC; de Vries WB; Nuytemans DHGM; van Overmeire B; Mulder AL; de Boode WP;
Trials; 2021 Sep; 22(1):627. PubMed ID: 34526095
[TBL] [Abstract][Full Text] [Related]
17. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
Malviya M; Ohlsson A; Shah S
Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
[TBL] [Abstract][Full Text] [Related]
18. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews.
Mitra S; de Boode WP; Weisz DE; Shah PS
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013588. PubMed ID: 37039501
[TBL] [Abstract][Full Text] [Related]
19. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Walia R; Shah S
Cochrane Database Syst Rev; 2005 Oct; (4):CD003481. PubMed ID: 16235321
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
Liebowitz M; Clyman RI
J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
